LEXX
Price
$0.87
Change
-$0.01 (-1.14%)
Updated
Sep 2, 04:57 PM (EDT)
Capitalization
17.22M
57 days until earnings call
PPBT
Price
$1.42
Change
-$0.57 (-28.64%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
6.04M
Interact to see
Advertisement

LEXX vs PPBT

Header iconLEXX vs PPBT Comparison
Open Charts LEXX vs PPBTBanner chart's image
Lexaria Bioscience
Price$0.87
Change-$0.01 (-1.14%)
Volume$384
Capitalization17.22M
Purple Biotech
Price$1.42
Change-$0.57 (-28.64%)
Volume$900
Capitalization6.04M
LEXX vs PPBT Comparison Chart in %
Loading...
LEXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PPBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LEXX vs. PPBT commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LEXX is a Buy and PPBT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (LEXX: $0.88 vs. PPBT: $1.99)
Brand notoriety: LEXX and PPBT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LEXX: 26% vs. PPBT: 72%
Market capitalization -- LEXX: $17.33M vs. PPBT: $4.69M
LEXX [@Biotechnology] is valued at $17.33M. PPBT’s [@Biotechnology] market capitalization is $4.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $102.81B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LEXX’s FA Score shows that 0 FA rating(s) are green whilePPBT’s FA Score has 1 green FA rating(s).

  • LEXX’s FA Score: 0 green, 5 red.
  • PPBT’s FA Score: 1 green, 4 red.
According to our system of comparison, both LEXX and PPBT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LEXX’s TA Score shows that 4 TA indicator(s) are bullish while PPBT’s TA Score has 4 bullish TA indicator(s).

  • LEXX’s TA Score: 4 bullish, 6 bearish.
  • PPBT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PPBT is a better buy in the short-term than LEXX.

Price Growth

LEXX (@Biotechnology) experienced а +11.04% price change this week, while PPBT (@Biotechnology) price change was -13.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

LEXX is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LEXX($17.2M) has a higher market cap than PPBT($6.04M). PPBT (-57.569) and LEXX (-58.081) have similar YTD gains . PPBT has higher annual earnings (EBITDA): -2.43M vs. LEXX (-11.31M). PPBT has more cash in the bank: 5.92M vs. LEXX (4.63M). PPBT has less debt than LEXX: PPBT (103K) vs LEXX (117K). LEXX has higher revenues than PPBT: LEXX (616K) vs PPBT (0).
LEXXPPBTLEXX / PPBT
Capitalization17.2M6.04M285%
EBITDA-11.31M-2.43M465%
Gain YTD-58.081-57.569101%
P/E RatioN/A0.00-
Revenue616K0-
Total Cash4.63M5.92M78%
Total Debt117K103K114%
FUNDAMENTALS RATINGS
LEXX vs PPBT: Fundamental Ratings
LEXX
PPBT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
24
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9994
PRICE GROWTH RATING
1..100
8889
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5019

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PPBT's Valuation (24) in the Pharmaceuticals Major industry is in the same range as LEXX (36) in the null industry. This means that PPBT’s stock grew similarly to LEXX’s over the last 12 months.

PPBT's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as LEXX (100) in the null industry. This means that PPBT’s stock grew similarly to LEXX’s over the last 12 months.

PPBT's SMR Rating (94) in the Pharmaceuticals Major industry is in the same range as LEXX (99) in the null industry. This means that PPBT’s stock grew similarly to LEXX’s over the last 12 months.

LEXX's Price Growth Rating (88) in the null industry is in the same range as PPBT (89) in the Pharmaceuticals Major industry. This means that LEXX’s stock grew similarly to PPBT’s over the last 12 months.

LEXX's P/E Growth Rating (100) in the null industry is in the same range as PPBT (100) in the Pharmaceuticals Major industry. This means that LEXX’s stock grew similarly to PPBT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LEXXPPBT
RSI
ODDS (%)
Bearish Trend 5 days ago
80%
Bullish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 5 days ago
80%
Momentum
ODDS (%)
Bullish Trend 5 days ago
85%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bullish Trend 5 days ago
75%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
85%
Bearish Trend 5 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
87%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 14 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
82%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
LEXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PPBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OSRH0.780.04
+4.90%
OSR Holdings Inc.
TSHA2.920.09
+3.18%
Taysha Gene Therapies
AVAL3.33-0.02
-0.58%
Grupo Aval Acciones Y Valores SA
NUE148.73-1.07
-0.71%
Nucor Corp
DERM7.21-0.06
-0.83%
Journey Medical Corp

LEXX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LEXX has been loosely correlated with PDSB. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if LEXX jumps, then PDSB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEXX
1D Price
Change %
LEXX100%
-1.09%
PDSB - LEXX
34%
Loosely correlated
N/A
CRBU - LEXX
28%
Poorly correlated
-3.61%
OCGN - LEXX
27%
Poorly correlated
-2.86%
PPBT - LEXX
26%
Poorly correlated
-12.33%
ERAS - LEXX
25%
Poorly correlated
N/A
More

PPBT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PPBT has been loosely correlated with SNTI. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if PPBT jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PPBT
1D Price
Change %
PPBT100%
-12.33%
SNTI - PPBT
64%
Loosely correlated
-5.16%
JANX - PPBT
36%
Loosely correlated
-1.43%
DARE - PPBT
31%
Poorly correlated
-0.25%
IMUX - PPBT
26%
Poorly correlated
-5.75%
LEXX - PPBT
26%
Poorly correlated
-1.09%
More